Brodowski Lars, Burlakov Jennifer, Hass Sarah, von Kaisenberg Constantin, von Versen-Höynck Frauke
Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany.
PLoS One. 2017 May 23;12(5):e0178340. doi: 10.1371/journal.pone.0178340. eCollection 2017.
Preeclampsia is one of the main contributers to maternal and fetal morbidity and mortality during pregnancy. A history of preeclampsia puts mother and offspring at an increased cardiovascular risk in later life. We hypothesized that at the time of birth functional impairments of fetal endothelial cells can be detected in pregnancies complicated by preeclampsia and that a therapeutic intervention using 1,25 (OH)2 vitamin D3 can reverse the adverse effects of preeclampsia on cell function.
Human umbilical vein endothelial cells (HUVEC) were isolated from umbilical cords obtained from preeclamptic (N = 12) and uncomplicated pregnancies (N = 13, control). Placental villous tissue fragments from uncomplicated term pregnancies were incubated in explant culture for 48 h at 2% (hypoxia), 8% or 21% O2. Explant conditioned media (CM) was collected and pooled according to oxygen level. We compared the ability of preeclampsia vs. control HUVEC to migrate, proliferate, and form tubule-like networks in a Matrigel assay, in the presence/absence of CM and 1,25(OH)2 vitamin D3.
HUVEC from preeclamptic pregnancies showed reduced migration (P = 0.04) and tubule formation (P = 0.04), but no change in proliferation (P = 0.16) compared to healthy pregnancies. Placental villous explant CM derived from 2% O2 incubations significantly reduced HUVEC migration, when compared to non-CM (P = 0.04). Vitamin D3 improved HUVEC function in neither of the groups. There was no significant difference in VEGF gene expression between healthy and preeclamptic pregnancies and no effect of Vitamin D3 on VEGF expression.
Reduced functional abilities of fetal endothelial cells from preeclamptic pregnancies suggests that disease pathways, possibly originating from the dysfunctional placenta, negatively impact fetal endothelium. The neutral effect of 1,25(OH)2 vitamin D3 contrasts with previous findings that vitamin D rescues the poor migration, proliferation and tubule formation exhibited by cord blood fetal endothelial progenitor cells from preeclamptic pregnancies. Further investigations to distinguish pathways by which offspring exposed to preeclampsia are at risk for cardiovascular disease are needed.
子痫前期是孕期孕产妇和胎儿发病及死亡的主要原因之一。子痫前期病史会使母亲和后代在日后生活中心血管疾病风险增加。我们假设,在子痫前期合并妊娠中,出生时可检测到胎儿内皮细胞的功能受损,并且使用1,25(OH)₂维生素D₃进行治疗干预可逆转子痫前期对细胞功能的不良影响。
从子痫前期孕妇(N = 12)和正常妊娠孕妇(N = 13,对照组)的脐带中分离人脐静脉内皮细胞(HUVEC)。将正常足月妊娠的胎盘绒毛组织碎片在2%(低氧)、8%或21%氧气条件下进行外植体培养48小时。根据氧气水平收集并合并外植体条件培养基(CM)。我们比较了子痫前期组与对照组HUVEC在有/无CM和1,25(OH)₂维生素D₃存在的情况下,在基质胶试验中迁移、增殖和形成管状网络的能力。
与健康妊娠相比,子痫前期妊娠的HUVEC迁移能力降低(P = 0.04),管状结构形成能力降低(P = 0.04),但增殖能力无变化(P = 0.16)。与无CM相比,来自2%氧气培养的胎盘绒毛外植体CM显著降低了HUVEC迁移能力(P = 0.04)。维生素D₃在两组中均未改善HUVEC功能。健康妊娠和子痫前期妊娠之间VEGF基因表达无显著差异,维生素D₃对VEGF表达无影响。
子痫前期妊娠胎儿内皮细胞功能能力降低表明,可能起源于功能失调胎盘的疾病途径会对胎儿内皮产生负面影响。1,25(OH)₂维生素D₃的中性作用与之前的研究结果形成对比,之前的研究发现维生素D可挽救子痫前期妊娠脐带血胎儿内皮祖细胞表现出的迁移、增殖和管状结构形成能力差的问题。需要进一步研究以区分子痫前期暴露后代患心血管疾病的风险途径。